Myriad Genetics (MYGN) Tops Q1 EPS by 5c, Beats on Revenues; Offers FY18 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Myriad Genetics (MYGN) Tops Q1 EPS by 5c, Beats on Revenues; Offers FY18 EPS Guidance

Myriad Genetics (MYGN) PT Raised to $26 at Morgan Stanley

November 8, 2017 8:43 AM EST

Morgan Stanley raised its price target on Myriad Genetics (NASDAQ: MYGN) to $26.00 (from $24.00) while maintaining a Underweight rating.

... More